-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Sarepta Therapeutics, Inc. annual/quarterly Current Federal Tax Expense (Benefit) history and growth rate from Q1 2023 to Q2 2023.
- Sarepta Therapeutics, Inc. Current Federal Tax Expense (Benefit) for the quarter ending June 30, 2023 was $2.9M.
- Sarepta Therapeutics, Inc. annual Current Federal Tax Expense (Benefit) for 2023 was $4.18M.
- Sarepta Therapeutics, Inc. annual Current Federal Tax Expense (Benefit) for 2022 was $0.000.
- Sarepta Therapeutics, Inc. annual Current Federal Tax Expense (Benefit) for 2021 was $0.000, a 100% decline from 2020.
Current Federal Tax Expense (Benefit), Quarterly (USD)